Source:http://linkedlifedata.com/resource/pubmed/id/16638224
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2006-4-26
|
pubmed:abstractText |
To explore the efficacy and safety of high-dose of etoposide with granulocyte colony-stimulating factor (G-CSF) for mobilization of peripheral blood stem cells, 10 patients with hematologic malignancies including 6 patients with multiple myeloma and 4 with non Hodgkin' s lymphoma received an etoposide dose of 1.6 g/m2. The total dose of undiluted etoposide was given on day 1 as a continuous intravenous infusion via a central vein for 10 hours. G-CSF 5 microg/kg was used on day 3 and given daily subcutaneously until leukopheresis was completed. The results showed that leukopheresis was started at days 11 (range 9-13 days) following etoposide therapy, the mean number of CD34+ cells collected in all 10 patients was 9.4 x 10(6)/kg (range 4.2 - 17.3 x 10(6)/kg), by an average of 2.6 leukophereses (range 1-4) times. Mobilization procedure that produced yields of greater than 4.0 x 10(6)/kg were achieved in every patient. Toxicity showed oropharyngeal mucositis, faucitis and urethritis respectively in 3 patients. It is concluded that high-dose etoposide with G-CSF is an effective and safe mobilizing regimen for autologous peripheral blood stem progenitor cells in patients with hematologic malignancies.
|
pubmed:language |
chi
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1009-2137
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
397-9
|
pubmed:meshHeading |
pubmed-meshheading:16638224-Adolescent,
pubmed-meshheading:16638224-Adult,
pubmed-meshheading:16638224-Aged,
pubmed-meshheading:16638224-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:16638224-Etoposide,
pubmed-meshheading:16638224-Female,
pubmed-meshheading:16638224-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:16638224-Hematologic Neoplasms,
pubmed-meshheading:16638224-Hematopoietic Stem Cell Mobilization,
pubmed-meshheading:16638224-Humans,
pubmed-meshheading:16638224-Male,
pubmed-meshheading:16638224-Middle Aged,
pubmed-meshheading:16638224-Peripheral Blood Stem Cell Transplantation,
pubmed-meshheading:16638224-Transplantation, Homologous
|
pubmed:year |
2006
|
pubmed:articleTitle |
[High-dose etoposide with granulocyte colony-stimulating factor for mobilization of autologous peripheral blood stem/progenitor cells in patients with hematologic malignancies].
|
pubmed:affiliation |
Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Research Support, Non-U.S. Gov't
|